Aethlon Medical (NASDAQ: BRKR) and Bruker (NASDAQ:BRKR) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

Institutional & Insider Ownership

7.4% of Aethlon Medical shares are held by institutional investors. Comparatively, 65.6% of Bruker shares are held by institutional investors. 6.6% of Aethlon Medical shares are held by company insiders. Comparatively, 35.2% of Bruker shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

Aethlon Medical has a beta of 1.93, suggesting that its stock price is 93% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.

Dividends

Bruker pays an annual dividend of $0.16 per share and has a dividend yield of 0.5%. Aethlon Medical does not pay a dividend. Bruker pays out 13.2% of its earnings in the form of a dividend.

Profitability

This table compares Aethlon Medical and Bruker’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Aethlon Medical N/A -126.58% -96.36%
Bruker 4.99% 27.03% 10.92%

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Aethlon Medical and Bruker, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aethlon Medical 0 0 1 0 3.00
Bruker 1 7 1 0 2.00

Aethlon Medical currently has a consensus price target of $3.00, suggesting a potential upside of 222.58%. Bruker has a consensus price target of $33.11, suggesting a potential downside of 6.57%. Given Aethlon Medical’s stronger consensus rating and higher probable upside, equities analysts plainly believe Aethlon Medical is more favorable than Bruker.

Earnings & Valuation

This table compares Aethlon Medical and Bruker’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aethlon Medical $150,000.00 110.36 -$5.67 million ($0.46) -2.02
Bruker $1.77 billion 3.14 $78.60 million $1.21 29.29

Bruker has higher revenue and earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

Summary

Bruker beats Aethlon Medical on 9 of the 14 factors compared between the two stocks.

About Aethlon Medical

Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.

About Bruker

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.